Securities code: Winner Medical Co.Ltd(300888) securities abbreviation: Winner Medical Co.Ltd(300888) Announcement No.: 2022013 Winner Medical Co.Ltd(300888)
Announcement on the resolution of the fifth meeting of the third board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
Winner Medical Co.Ltd(300888) (hereinafter referred to as “the company”) the fifth meeting of the third board of directors was held on Friday, April 8, 2022 in the form of on-site communication. The notice of the meeting was sent to all directors by mail and telephone on April 6, 2022. There were 7 directors who should attend the meeting and 7 actually attended the meeting. Affected by the epidemic prevention and control, the directors Mr. Guo Zhenwei, Ms. Xie Jiawei, Mr. Peng Jianfeng and Mr. key Ke Liu (Liu Ke) attended the meeting by means of communication. The meeting was convened and presided over by Mr. Li Jianquan, chairman of the board of directors. The supervisors and senior managers of the company attended the meeting as nonvoting delegates. The meeting was held in accordance with the relevant provisions of the company law and the articles of association.
2、 Deliberations of the board meeting
The directors attending the meeting fully discussed the proposals to be considered at the meeting, and considered and adopted the following proposals:
1. Deliberated and passed the proposal on purchasing 55% equity of Longtai medical.
In order to further enrich the company’s product line, expand the company’s overseas business channels and improve the company’s strategic layout, the board of directors agreed that the company would use its own funds of RMB 727.54 million to acquire 55% equity of Zhejiang Longtai Medical Technology Co., Ltd. held by Mr. Wu Kangping, Ms. Huang Lepei and Mr. Wu Di, The main business of Zhejiang Longtai medical Polytron Technologies Inc is the development, production and sale of high-end wound dressing (including silicone foam, hydrocolloid, silicone gel, hydrogel, film applicator and stoma).
The board of directors agreed to authorize Mr. Li Jianquan, chairman of the board of directors, to sign documents related to this transaction on behalf of the company (including but not limited to equity transfer agreement and articles of association of the target company)
For details, please refer to the company’s disclosure on cninfo (www.cn. Info. Com. CN.) on the same day Announcement on the acquisition of 55% equity of Longtai medical (Announcement No.: 2022014).
Voting results: 7 in favor, 0 against and 0 abstention.
3、 Documents for future reference
1. Resolutions of the 5th meeting of the 3rd board of directors;
It is hereby announced.
Winner Medical Co.Ltd(300888) board of directors April 11, 2002
